MiR-320d as a regulator of airway inflammation in COPD

Mirjam P. Roffel (Groningen, Netherlands)

Source: ERS Lung Science Conference 2020
Number: 22
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mirjam P. Roffel (Groningen, Netherlands). MiR-320d as a regulator of airway inflammation in COPD. ERS Lung Science Conference 2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
MiR-320d has a regulatory effect in airway inflammation in COPD
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020

Airway inflammation markers in COPD
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Year: 2007


Modulation of Eosinophilic airway inflammation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005

Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006

Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009


Inflammatory cells and airway remodelling in COPD
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019


The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014

Allergen-induced airway remodelling
Source: Eur Respir J 2007; 29: 1020-1032
Year: 2007



Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


Low-level laser therapy effect on the bronchial hyperresponsiveness and the chronic allergy airway inflammation is driven to RhoA signaling and STAT-6
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013

Chronic sputum production in COPD is a marker for airway inflammation and colonisation
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004

Autoimmunity  in airway inflammation and asthma
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017


Inhaled insulin does not trigger lung inflammation and airway remodelling
Source: Eur Respir J 2009; 33: 444-445
Year: 2009


Let-7 promotes airway remodeling via regulation of IL-6 in chronic obstruction pulmonary disease
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020

Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011